Daiichi Sankyo Showcases Oncology Progress at ESMO Asia, SABCS, and ASH
Daiichi Sankyo will present over 45 abstracts highlighting the progress across its oncology portfolio at the 2024 ESMO Asia Congress,San Antonio Breast Cancer Symposium and The American Society of Hematology…
New Biovanta Study Demonstrates Highest Efficacy in Treating Common Cold
Common cold viruses cause substantial productivity losses and negatively impact overall well-being, with an estimated $40 billion lost annually in the United States alone. However, a new study published in…
Melinta Joins NHIA’s Future of Infusion Advisory Council
The National Home Infusion Association (NHIA) and Melinta Therapeutics, LLC, a biopharmaceutical company specializing in innovative therapies for acute and life-threatening conditions, are excited to announce Melinta’s membership in NHIA’s…
Revolution Medicines Shares Clinical Updates on RAS(ON) Inhibitor Portfolio
Revolution Medicines a clinical-stage oncology company developing targeted therapies for RAS-driven cancers, announced significant clinical updates from its RAS(ON) inhibitor portfolio. The data, presented during an investor webcast, focused on…
Orion’s Nordic Pharmaceutical Manufacturing Ensures Security Across Europe
Orion ensures a steady supply of medicines by manufacturing them in its own facilities, while its subsidiary Fermion produces the active pharmaceutical ingredients (APIs) for these medicines. This integrated production…
CHMP Backs Palforzia for Treating Peanut Allergy in Toddlers
Stallergenes Greer, a leading biopharmaceutical company specializing in allergen immunotherapy (AIT), announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has…
GE HealthCare to Fully Acquire Nihon Medi-Physics from Sumitomo Chemical
GE HealthCare (Nasdaq: GEHC) has reached an agreement to acquire the remaining 50% stake in Nihon Medi-Physics Co., Ltd. (NMP) from Sumitomo Chemical (TYO: 4005), giving it full ownership of…
Digital Twins: Advancing Clinical Research and Bridging Data Gaps
Projected to surpass $38 billion in value by 2032, artificial intelligence (AI) simulations—particularly digital twins—are reshaping the healthcare landscape. These virtual replicas of individuals possess an uncanny ability to replicate…
FDA Accelerated Approval Boosts Hope for Fatal Diseases
Despite criticism stemming from contentious biomarkers and failed confirmatory trials, the FDA’s accelerated approval pathway continues to drive therapeutic innovation for some of the world’s most complex and pressing medical…
Biopharma Tackles Deadly Brain Cancer After Years of Setbacks
Technological breakthroughs and deeper insights into glioblastoma are revitalizing efforts to tackle this aggressive brain tumor. Companies like Merck, Kazia Therapeutics, CorriXR Therapeutics, and others are leading the charge, raising…
GE HealthCare Showcases AI-Driven Innovations and Precision Care Solutions at RSNA 2024
At the 2024 Annual Meeting of the Radiological Society of North America (RSNA), held December 1-4 in Chicago, GE HealthCare (Nasdaq: GEHC) is presenting over 40 groundbreaking innovations. These include…
Laser Photonics Launches R&D Initiative to Drive Innovation
Laser Photonics Corporation a global leader in the development of industrial laser systems for material processing applications, has announced the launch of a new research and development (R&D) initiative aimed…